| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H4K16 acetyltransferase activity | 1.13e-04 | 9 | 36 | 2 | GO:0046972 | |
| GeneOntologyMolecularFunction | protein-glutamic acid ligase activity | 1.41e-04 | 10 | 36 | 2 | GO:0070739 | |
| GeneOntologyMolecularFunction | tubulin-glutamic acid ligase activity | 1.41e-04 | 10 | 36 | 2 | GO:0070740 | |
| GeneOntologyMolecularFunction | acid-amino acid ligase activity | 7.81e-04 | 23 | 36 | 2 | GO:0016881 | |
| GeneOntologyMolecularFunction | histone H4 acetyltransferase activity | 7.81e-04 | 23 | 36 | 2 | GO:0010485 | |
| GeneOntologyMolecularFunction | snoRNA binding | 1.71e-03 | 34 | 36 | 2 | GO:0030515 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic density organization | 1.27e-05 | 27 | 35 | 3 | GO:1905874 | |
| GeneOntologyBiologicalProcess | postsynaptic density organization | 1.30e-04 | 58 | 35 | 3 | GO:0097106 | |
| GeneOntologyBiologicalProcess | protein polyglutamylation | 2.16e-04 | 13 | 35 | 2 | GO:0018095 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization organization | 2.36e-04 | 71 | 35 | 3 | GO:0099084 | |
| GeneOntologyCellularComponent | Pwp2p-containing subcomplex of 90S preribosome | 4.31e-05 | 6 | 36 | 2 | GO:0034388 | |
| Domain | HAT | 1.52e-04 | 10 | 35 | 2 | IPR003107 | |
| Domain | HAT | 1.52e-04 | 10 | 35 | 2 | SM00386 | |
| Domain | TTL | 2.63e-04 | 13 | 35 | 2 | PS51221 | |
| Domain | TTL/TTLL_fam | 2.63e-04 | 13 | 35 | 2 | IPR004344 | |
| Domain | TTL | 2.63e-04 | 13 | 35 | 2 | PF03133 | |
| Domain | ATP_grasp_subdomain_2 | 1.53e-03 | 31 | 35 | 2 | IPR013816 | |
| Domain | PTPc | 2.07e-03 | 36 | 35 | 2 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 2.42e-03 | 39 | 35 | 2 | PS50055 | |
| Domain | PTPase_domain | 2.67e-03 | 41 | 35 | 2 | IPR000242 | |
| Domain | Y_phosphatase | 2.67e-03 | 41 | 35 | 2 | PF00102 | |
| Domain | fn3 | 3.42e-03 | 162 | 35 | 3 | PF00041 | |
| Domain | FN3 | 4.96e-03 | 185 | 35 | 3 | SM00060 | |
| Domain | Ig_I-set | 5.34e-03 | 190 | 35 | 3 | IPR013098 | |
| Domain | ig | 5.34e-03 | 190 | 35 | 3 | PF00047 | |
| Domain | Immunoglobulin | 5.34e-03 | 190 | 35 | 3 | IPR013151 | |
| Domain | I-set | 5.34e-03 | 190 | 35 | 3 | PF07679 | |
| Domain | PTPc_motif | 5.46e-03 | 59 | 35 | 2 | SM00404 | |
| Domain | Tyr_Pase_cat | 5.46e-03 | 59 | 35 | 2 | IPR003595 | |
| Domain | FN3 | 6.07e-03 | 199 | 35 | 3 | PS50853 | |
| Domain | FN3_dom | 6.95e-03 | 209 | 35 | 3 | IPR003961 | |
| Domain | Tyr_Pase_AS | 8.25e-03 | 73 | 35 | 2 | IPR016130 | |
| Domain | IGc2 | 9.57e-03 | 235 | 35 | 3 | SM00408 | |
| Domain | Ig_sub2 | 9.57e-03 | 235 | 35 | 3 | IPR003598 | |
| Domain | TYR_PHOSPHATASE_1 | 1.13e-02 | 86 | 35 | 2 | PS00383 | |
| Domain | TYR_PHOSPHATASE_2 | 1.16e-02 | 87 | 35 | 2 | PS50056 | |
| Domain | TYR_PHOSPHATASE_dom | 1.16e-02 | 87 | 35 | 2 | IPR000387 | |
| Domain | - | 1.29e-02 | 92 | 35 | 2 | 3.90.190.10 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 6.57e-04 | 20 | 27 | 2 | M27290 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 6.57e-04 | 20 | 27 | 2 | MM14991 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 6.57e-04 | 20 | 27 | 2 | MM15485 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 7.25e-04 | 21 | 27 | 2 | M27736 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 1.20e-03 | 27 | 27 | 2 | MM15549 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 9566880 | ||
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 3.12e-06 | 3 | 36 | 2 | 31985401 | |
| Pubmed | Structural basis for LAR-RPTP/Slitrk complex-mediated synaptic adhesion. | 3.12e-06 | 3 | 36 | 2 | 25394468 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 20139422 | ||
| Pubmed | Genome-wide association study of copy number variations (CNVs) with opioid dependence. | 3.12e-06 | 3 | 36 | 2 | 25345593 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 9784606 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 3.12e-06 | 3 | 36 | 2 | 33656439 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 8524829 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 22357843 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 10777529 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 38388459 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 19273906 | ||
| Pubmed | Mammalian motoneuron axon targeting requires receptor protein tyrosine phosphatases sigma and delta. | 1.56e-05 | 6 | 36 | 2 | 16738228 | |
| Pubmed | Receptor protein tyrosine phosphatases are novel components of a polycystin complex. | 1.56e-05 | 6 | 36 | 2 | 21126580 | |
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 29073098 | ||
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 23345436 | ||
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 12376545 | ||
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 28637841 | ||
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 37591863 | ||
| Pubmed | 5.70e-05 | 11 | 36 | 2 | 25624497 | ||
| Pubmed | 5.70e-05 | 11 | 36 | 2 | 7832766 | ||
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 6.83e-05 | 12 | 36 | 2 | 9624153 | |
| Pubmed | 6.83e-05 | 12 | 36 | 2 | 31875546 | ||
| Pubmed | A targeted multienzyme mechanism for selective microtubule polyglutamylation. | 8.07e-05 | 13 | 36 | 2 | 17499049 | |
| Pubmed | Protein tyrosine phosphatases expression during development of mouse superior colliculus. | 1.40e-04 | 17 | 36 | 2 | 19727691 | |
| Pubmed | Klf4 glutamylation is required for cell reprogramming and early embryonic development in mice. | 3.08e-04 | 25 | 36 | 2 | 29593216 | |
| Pubmed | 3.33e-04 | 26 | 36 | 2 | 36178190 | ||
| Pubmed | 5.07e-04 | 32 | 36 | 2 | 14613977 | ||
| Pubmed | 5.62e-04 | 660 | 36 | 5 | 32780723 | ||
| Pubmed | Choroid plexuses carry nodal-like cilia that undergo axoneme regression from early adult stage. | 6.07e-04 | 35 | 36 | 2 | 37890489 | |
| Pubmed | 6.33e-04 | 162 | 36 | 3 | 25826454 | ||
| Pubmed | The Type 3 Deiodinase Is a Critical Modulator of Thyroid Hormone Sensitivity in the Fetal Brain. | 1.00e-03 | 45 | 36 | 2 | 34248495 | |
| Interaction | TSNAXIP1 interactions | 7.22e-06 | 22 | 35 | 3 | int:TSNAXIP1 | |
| Interaction | SLITRK1 interactions | 4.38e-05 | 6 | 35 | 2 | int:SLITRK1 | |
| Cytoband | 5q31.1 | 1.13e-03 | 63 | 36 | 2 | 5q31.1 | |
| GeneFamily | WD repeat domain containing|UTPB complex | 2.74e-05 | 6 | 25 | 2 | 1225 | |
| GeneFamily | Tubulin tyrosine ligase family | 1.65e-04 | 14 | 25 | 2 | 779 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 3.79e-04 | 21 | 25 | 2 | 813 | |
| GeneFamily | Fibronectin type III domain containing | 1.36e-03 | 160 | 25 | 3 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.38e-03 | 161 | 25 | 3 | 593 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.74e-05 | 193 | 36 | 4 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.84e-05 | 196 | 36 | 4 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.84e-05 | 196 | 36 | 4 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.88e-05 | 197 | 36 | 4 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.92e-05 | 198 | 36 | 4 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar-Club_cell|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.00e-04 | 162 | 36 | 3 | aed15eef32419b8a4e2afdb9776c2bf2802e96f1 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.11e-04 | 164 | 36 | 3 | 519ab4fe885dfe4c50846f346a062acc2cb44299 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.22e-04 | 166 | 36 | 3 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | Tuft-tuft-1|World / Class top | 3.34e-04 | 168 | 36 | 3 | 8ddc2ec483ed2c6c0fb2ae521c6861ceb6d32e34 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.45e-04 | 170 | 36 | 3 | 51dbfa07daf6f972b566f3f6abe7f46e080ec01c | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-04 | 170 | 36 | 3 | 10e0912dd0beab5d0bbe2bd49e477b5962687925 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.01e-04 | 179 | 36 | 3 | e860dca9b28ac5af61804bfd729cd39257cdb352 | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.15e-04 | 181 | 36 | 3 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.21e-04 | 182 | 36 | 3 | ba066ff9029cc052b76e2330ec168cb2e9b7e498 | |
| ToppCell | P28-Mesenchymal|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.21e-04 | 182 | 36 | 3 | 69f9d44694fe4f55a971ae0ac5dc3e7448ee78f3 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.56e-04 | 187 | 36 | 3 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.56e-04 | 187 | 36 | 3 | 689b3cc76f1e04bd35a7d3ce19e9f08744a7835b | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.56e-04 | 187 | 36 | 3 | 4527d6426f2c4397e47f12439a13a8c14fd2aab2 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.56e-04 | 187 | 36 | 3 | 3912bbb610a4a84791e9bda92a2d57a52c31d29e | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 4.56e-04 | 187 | 36 | 3 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.63e-04 | 188 | 36 | 3 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Undetermined|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 4.63e-04 | 188 | 36 | 3 | 8231e635706a296db6b6da1029a33bbc1b52478e | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.70e-04 | 189 | 36 | 3 | 46c5b975fb9d33017f2d9b7770d45a8bdf95baa2 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-04 | 189 | 36 | 3 | d00410010283dc6191ce9857d6c7952678fed588 | |
| ToppCell | P03-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.70e-04 | 189 | 36 | 3 | b5439ef221106f6d54434f268485e9bb17b39102 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.78e-04 | 190 | 36 | 3 | e102622f05c7f3e1bd8b224ea159d57033793ee0 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.85e-04 | 191 | 36 | 3 | 44a9a6768084dafc641ad455b65862bfd4cc0cb9 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.85e-04 | 191 | 36 | 3 | de2cd94ee88a7754f86d39469e38374d668210c7 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.85e-04 | 191 | 36 | 3 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.85e-04 | 191 | 36 | 3 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.85e-04 | 191 | 36 | 3 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.85e-04 | 191 | 36 | 3 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.92e-04 | 192 | 36 | 3 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.92e-04 | 192 | 36 | 3 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | droplet-Lung-1m-Mesenchymal|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.92e-04 | 192 | 36 | 3 | 01433bd4794b8bcc51fe4249124a0f4289b9d6e2 | |
| ToppCell | droplet-Lung-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.92e-04 | 192 | 36 | 3 | 086b47f87283cd41139cd56686011f8b5821b0da | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.92e-04 | 192 | 36 | 3 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.92e-04 | 192 | 36 | 3 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.00e-04 | 193 | 36 | 3 | 173f1d83133f5ffa88e2a75d28835ad7acd2aa90 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.00e-04 | 193 | 36 | 3 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | B_cell_maturation-plasma|B_cell_maturation / Lineage and Cell class | 5.00e-04 | 193 | 36 | 3 | 5415f7e54bc40aec3dbe27fd97f6e9be6db08a48 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.00e-04 | 193 | 36 | 3 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | (1)_Osterolineage_cells|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 5.00e-04 | 193 | 36 | 3 | 035eeea9f77c4bf9cd85f07fa791b6c857be76b5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.00e-04 | 193 | 36 | 3 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.00e-04 | 193 | 36 | 3 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.08e-04 | 194 | 36 | 3 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.08e-04 | 194 | 36 | 3 | 811b382ec3da06a6bda7360abc8b633f96b2019e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.08e-04 | 194 | 36 | 3 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.08e-04 | 194 | 36 | 3 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | PND07-28-samps-Mesenchymal|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.08e-04 | 194 | 36 | 3 | 68bcc1fe8dc8d5f23a12154fc9b41362fdef0b1d | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.08e-04 | 194 | 36 | 3 | 292ce9021678534c9eedb367b9772a9d976208a8 | |
| ToppCell | metastatic_Brain-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 5.08e-04 | 194 | 36 | 3 | 69828d24b3e182f26aa15eb0ae5aa21c640c2922 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.08e-04 | 194 | 36 | 3 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 5.15e-04 | 195 | 36 | 3 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | (1)_Osterolineage_cells-(11)_OLC-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 5.15e-04 | 195 | 36 | 3 | 78978d85273e5463a7f43e4c121e647fa6aba42b | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 5.15e-04 | 195 | 36 | 3 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.15e-04 | 195 | 36 | 3 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.23e-04 | 196 | 36 | 3 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-04 | 196 | 36 | 3 | 44f5b1b474399c9316729155f2ea95a82ca66e30 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-04 | 196 | 36 | 3 | fcb275746bf51269ed8ba4cf93edb054a45f1ccd | |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-04 | 196 | 36 | 3 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.23e-04 | 196 | 36 | 3 | d5ed41fa111750e6b363c04cccc40a47dd774852 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.23e-04 | 196 | 36 | 3 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 5.23e-04 | 196 | 36 | 3 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | PND28-Mesenchymal|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.23e-04 | 196 | 36 | 3 | 119265efd2219f328d8152dbee52af8327aec89c | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.23e-04 | 196 | 36 | 3 | 760885dc608c82768fe0decd63ed9fda8315f453 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-04 | 197 | 36 | 3 | 036c4c9b3ae80e2dc21c24a84504d3da0541f945 | |
| ToppCell | droplet-Bladder-BLADDER|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-04 | 197 | 36 | 3 | 5ae84f796005fa7b75d10b6464770da6cd5c8f53 | |
| ToppCell | droplet-Bladder-BLADDER-1m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-04 | 197 | 36 | 3 | 1e24150c5146c93914aaaa981bd17589e8ed7cf9 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.31e-04 | 197 | 36 | 3 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-04 | 198 | 36 | 3 | 8f202ed4692ea2c139ff05d4805c704ee4be095c | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.39e-04 | 198 | 36 | 3 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.39e-04 | 198 | 36 | 3 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 5.39e-04 | 198 | 36 | 3 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 5.39e-04 | 198 | 36 | 3 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.46e-04 | 199 | 36 | 3 | 7f4840ae6a888380feca722543e5e52783f3e35d | |
| ToppCell | proximal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.46e-04 | 199 | 36 | 3 | 301d02bbb37e6f1d24b6e865bc3fe3e91260eb30 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 5.46e-04 | 199 | 36 | 3 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.46e-04 | 199 | 36 | 3 | 9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.46e-04 | 199 | 36 | 3 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.46e-04 | 199 | 36 | 3 | 655d07cf9a2fd9b945a2ed4f824cba0297de72a8 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.46e-04 | 199 | 36 | 3 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.55e-04 | 200 | 36 | 3 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Mesenchymal-Unfolded_protein_responsible_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 5.55e-04 | 200 | 36 | 3 | bc479baca21f0ff19a1c4efdb9530f289a1ab115 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.55e-04 | 200 | 36 | 3 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.55e-04 | 200 | 36 | 3 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.55e-04 | 200 | 36 | 3 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.55e-04 | 200 | 36 | 3 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.55e-04 | 200 | 36 | 3 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.55e-04 | 200 | 36 | 3 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.55e-04 | 200 | 36 | 3 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.55e-04 | 200 | 36 | 3 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.55e-04 | 200 | 36 | 3 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.55e-04 | 200 | 36 | 3 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.55e-04 | 200 | 36 | 3 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.55e-04 | 200 | 36 | 3 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.55e-04 | 200 | 36 | 3 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.55e-04 | 200 | 36 | 3 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| Disease | vital capacity | 3.65e-04 | 1236 | 33 | 7 | EFO_0004312 | |
| Disease | azoospermia (implicated_via_orthology) | 4.18e-04 | 27 | 33 | 2 | DOID:14227 (implicated_via_orthology) | |
| Disease | dental caries | 1.19e-03 | 187 | 33 | 3 | EFO_0003819 | |
| Disease | white matter hyperintensity measurement | 4.61e-03 | 302 | 33 | 3 | EFO_0005665 | |
| Disease | subcutaneous adipose tissue measurement | 4.87e-03 | 93 | 33 | 2 | EFO_0004766 | |
| Disease | endometrial carcinoma | 7.10e-03 | 113 | 33 | 2 | EFO_1001512 | |
| Disease | pursuit maintenance gain measurement | 8.36e-03 | 123 | 33 | 2 | EFO_0008433 | |
| Disease | language measurement | 9.86e-03 | 134 | 33 | 2 | EFO_0007797 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EEMVEPLREKIRDLE | 56 | Q8NBZ7 | |
| PSEEMLELEKERREL | 211 | Q9Y2D5 | |
| MLRLSEVDIDDDERP | 141 | Q6UX04 | |
| EPTDVELEIMKRDEI | 1346 | Q96MT7 | |
| LIRMEEEEFFIEPLE | 181 | O95450 | |
| RLVPAAEEEELLREM | 326 | Q9Y4B5 | |
| EMEERTVTLEIPEVL | 91 | P0C860 | |
| RLEPEMVRMVVESVE | 236 | Q15742 | |
| EMERPELDELTLERV | 156 | Q9NQC1 | |
| EMEERTITIEIPEVL | 166 | Q8N5Y2 | |
| PEDMDLEELIQDISR | 1176 | Q13332 | |
| LPRELAKMIEEDTEE | 101 | Q8WVH0 | |
| MIRTPEELEDVSDLE | 626 | Q9UI47 | |
| RVEELEMTEDIRLEP | 806 | Q92896 | |
| VELEEVEFEMPRDRR | 116 | P57773 | |
| EDDVMERQRLIESVP | 416 | Q6V1X1 | |
| LEEIVKMEPEEAREE | 1321 | Q3T8J9 | |
| DELMEAVLERILAPE | 116 | P51168 | |
| PDEMELDELLKEISR | 1161 | P23468 | |
| MAEIIQERIEDRLPE | 1 | Q9NYH9 | |
| ILEIMSAVRDEDPLE | 266 | Q6P1N9 | |
| DPEEMIRGVDELERL | 71 | Q8IYN2 | |
| ELERIPLSEMTREEI | 91 | Q8WWX9 | |
| VELEEPEDARIMLSR | 411 | O94906 | |
| LSEVPLMILDEEREL | 141 | Q9NZH4 | |
| LERLEMPVAREHIEV | 71 | Q499Z3 | |
| EVELREMRTEAIARP | 161 | Q96AJ1 | |
| TMLEELEKELEEPRQ | 121 | Q86W11 | |
| KEPIVEMRTEDERVT | 766 | O15394 | |
| LEVPERLLVVLDMEE | 161 | Q99619 | |
| EIRAMDEIQPDLREL | 146 | Q9UK41 | |
| LTEMRLEPIIEDAVE | 271 | Q9NZI7 | |
| EREEKLLMVETETPR | 61 | Q9UJU3 | |
| REPLILEEEREMERE | 706 | Q9UNX4 | |
| LVREPDHMELEEDRA | 226 | Q9Y6M5 | |
| IDRPEAISEERLREM | 136 | Q9Y6B6 | |
| VLTPDDVRILVEMED | 1001 | Q14679 | |
| MRPQEIVEEEELERM | 581 | A6NNM8 |